Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
34.87
+1.28 (3.81%)
At close: Apr 28, 2026, 4:00 PM EDT
34.69
-0.18 (-0.52%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Sutro Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -191.09 | -227.46 | -106.79 | -119.2 | -105.54 | |
| Depreciation & Amortization | 7.32 | 7.22 | 6.82 | 5.69 | 4.84 | |
| Asset Writedown & Restructuring Costs | 1.69 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -3.44 | -41.86 | -18.99 | -16.57 | 7.24 | |
| Stock-Based Compensation | 14.01 | 24.69 | 24.91 | 26.3 | 23.24 | |
| Other Operating Activities | 44.66 | 36.97 | 16.82 | 2.92 | 6.16 | |
| Change in Accounts Receivable | 4.64 | 27.46 | -28.96 | 5.34 | -6.9 | |
| Change in Accounts Payable | -2.47 | 0.71 | 4.81 | -1.23 | 2.71 | |
| Change in Unearned Revenue | -69.73 | 7.85 | -32.6 | 93.65 | -15.21 | |
| Change in Other Net Operating Assets | 17.16 | -27.11 | 22.37 | 6.64 | 1.77 | |
| Operating Cash Flow | -177.23 | -191.54 | -111.62 | 3.55 | -81.68 | |
| Capital Expenditures | -1.7 | -3.1 | -4.32 | -7.86 | -15.32 | |
| Investment in Securities | 46.71 | 221.61 | 0.39 | -27.17 | -82 | |
| Other Investing Activities | - | - | - | 0.01 | 0.01 | |
| Investing Cash Flow | 45.01 | 218.51 | -3.92 | -35.02 | -97.32 | |
| Long-Term Debt Repaid | - | -4.08 | -12.5 | -9.38 | - | |
| Net Debt Issued (Repaid) | - | -4.08 | -12.5 | -9.38 | - | |
| Issuance of Common Stock | 0.38 | 98.65 | 14.34 | 58.15 | 4.25 | |
| Repurchase of Common Stock | -0.33 | -0.51 | -0.49 | -0.46 | -0.99 | |
| Other Financing Activities | - | - | 136.21 | - | - | |
| Financing Cash Flow | 0.04 | 94.05 | 137.55 | 48.31 | 3.26 | |
| Net Cash Flow | -132.17 | 121.02 | 22.01 | 16.84 | -175.74 | |
| Free Cash Flow | -178.93 | -194.64 | -115.93 | -4.31 | -97 | |
| Free Cash Flow Margin | -174.59% | -313.72% | -75.41% | -6.36% | -156.76% | |
| Free Cash Flow Per Share | -21.06 | -25.16 | -19.27 | -0.85 | -21.03 | |
| Cash Interest Paid | - | 0.31 | 1.13 | 1.87 | 2.05 | |
| Cash Income Tax Paid | -0.08 | 17.52 | 0.38 | - | 0.1 | |
| Levered Free Cash Flow | -112.39 | -78.99 | -36.57 | -41.16 | -59.62 | |
| Unlevered Free Cash Flow | -86.1 | -59.57 | -21.72 | -36.53 | -57.62 | |
| Change in Working Capital | -50.4 | 8.9 | -34.38 | 104.41 | -17.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.